Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes

International Journal of Pharmaceutics

Volumn 197, Issue 1-2, 2000, Pages 221-231

  Birchall, James C ^a   Kellaway, Ian W ^a   Gumbleton, Mark ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Aerosolisation; Cationic lipid; Gene therapy; Lung; Nebulisation; Plasmid DNA; Polycationic peptide; Protamine

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CATIONIC SURFACTANT; PLASMID DNA; PROTAMINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; DRUG FORMULATION; DRUG STABILITY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; NEBULIZATION; PARTICLE SIZE; PRIORITY JOURNAL;

DNA; DRUG CARRIERS; DRUG STABILITY; ELECTROPHORESIS; FATTY ACIDS, MONOUNSATURATED; FLUORESCENT DYES; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; LIPIDS; LIPOSOMES; MICROSCOPY, ELECTRON; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PEPTIDES; PROTAMINES; QUATERNARY AMMONIUM COMPOUNDS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034003204     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00339-2     Document Type: Article

References (33)

1. Alton E.W.F.W., Geddes D.M., Gill D.R. et al. Towards gene therapy for cystic fibrosis: a clinical progress report. Gene Ther. 5:1998;291-292.
2. Anchordoquy T.J., Carpenter J.F., Kroll D.J. Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. Arch. Biochem. Biophys. 348:1997;199-206.
3. Birchall, J.C., Kellaway, I.W., Mills, S.N. 1999. Physico-chemical characterisation of cationic lipid:plasmid DNA gene delivery complexes. Int J Pharm 183, 195-207.
4. Brown A.R., Chowdhury S.I. Propellant driven aerosols of DNA plasmids for gene expression in the respiratory tract. J. Aerosol. Med. 10:1997;129-146.
5. Canonico A.E., Conary J.T., Meyrick B., Brigham K.L. Aerosol and intravenous transfection of human alpha 1 antitrypsin gene to lungs of rabbits. Am. J. Respir. Cell Mol. Biol. 10:1994;249-255.
6. Conary J.T., Erdos G., McGuire M. et al. Cationic liposome plasmid DNA complexes: In vitro cell entry and transgene expression augmented by synthetic signal peptides. Eur. J. Pharm. Biopharm. 42:1996;277-285.
7. Conary J.T., Parker R.E., Christman B.W. et al. Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene. J. Clin. Invest. 93:1994;1834-1840.
8. Crook K., McLachlan G., Stevenson B.J., Porteus D.J. Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. Gene Ther. 3:1996;834-839.
9. Demoly P., Mathieu M., Curiel D.T., Goddard P.H., Bousquet J., Michel F.B. Gene therapy strategies for asthma. Gene Ther. 4:1997;507-516.
10. Eastman S.J., Tousignant J.D., Lukason M.J., Chu Q., Cheng S.H., Scheule R.K. Aerosolization of cationic lipid:pDNA complexes - in vitro optimization of nebulizer parameters for human clinical studies. Hum. Gene Ther. 9:1998;43-52.
11. Eastman S.J., Tousignant J.D., Lukason M.J. et al. Optimisation of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes. Hum. Gene Ther. 8:1997;313-322.
12. Gao X., Huang L. Potentiation of liposome-mediated gene delivery by polycations. Biochemistry. 35:1996;1027-1036.
13. Geddes D., Alton E. Cystic fibrosis clinical trials. Adv. Drug Delivery Rev. 30:1998;205-217.
14. Harris J.R. Electron microscopy in biology: a practical approach. 1991;Oxford University Press, Oxford.
15. Holzner, P., Sorgi, F.L., Hickey, A.J., Schreier, H. 1997. A novel approach for gene delivery to the lung using artificial viral envelopes as a dry powder aerosol. Pharm Res 14 (Suppl.), S-62 Abstract 1196.
16. Kaneda Y., Iwai K., Uchida T. Increased expression of DNA co-introduced with nuclear protein in adult rat liver. Science. 243:1989;375-378.
17. Lee E.R., Marshall J., Siegal C.S. et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 7:1996;1701-1717.
18. Li S., Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 4:1997;891-900.
19. Mahato R.I., Takakura Y., Hashida M. Development of targeted delivery systems for nucleic acid drugs. J. Drug Targeting. 4:1997;337-357.
20. Pierson R.N., Conary J.T., Langford G., White D.G., Brigham K.L., Parker R.E. Targeted in vivo gene transfection modulates hyperacute rejection of pig lungs perfused with human blood. Transfection Protocols. 28:1996;763.
21. Plank C., Oberhauser B., Mechtler K., Koch C., Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269:1994;12918-12924.
22. Porteous D.J., Dorin J.R., McLachlan G. et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4:1997;210-218.
23. Pouton C.W., Lucas P., Thomas B.J., Uduehi A.N., Milroy D.A., Moss S.H. Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J. Control. Rel. 53:1998;289-299.
24. Puyal C., Maurin L., Miquel G., Bienvenue A., Philippot J. Design of a short membrane-destabilising peptide covalently bound to liposomes. Biochim. Biophys. Acta. 1195:1994;259-266.
25. Rolland A.P. From genes to gene medicines: recent advances in nonviral gene delivery. Crit. Rev. Ther. Drug Carrier Syst. 15:1998;143-198.
26. Scheule R.K., St George J.A., Bagley R.G. et al. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to mammalian lung. Hum. Gene Ther. 8:1997;689-707.
27. Sheng S.H., Scheule R.K. Airway delivery of cationic lipid:DNA complexes for cystic fibrosis. Adv. Drug Delivery Rev. 30:1998;173-184.
28. Smith J., Zhang Y., Niven R. Toward development of a non-viral gene therapeutic. Adv. Drug Delivery Rev. 26:1997;135-150.
29. Sorgi F.L., Cagné L., Sharif S. et al. Aerosol gene delivery using the AERx™ delivery system. Proceed. Intl. Symp. Control. Rel. Bioact. Mater. 25:1998;184-185.
30. Sorgi F.L., Bhattacharya S., Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther. 4:1997;961-968.
31. Stern M., Sorgi F., Hughes C. et al. The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro. Gene Ther. 5:1998;583-593.
32. Tomlinson E., Rolland A.P. Controllable gene therapy. Pharmaceutics of non-viral gene delivery systems. J. Control. Rel. 39:1996;357-372.
33. Zabner K., Fasbender A.J., Moninger T., Poellinger K.A., Welsh M.J. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270:1995;18997-19007.